Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chin B Eap

Showing results (121-130 of 179) with videos related to

Pageof 18
Sort By:
The Journal of Clinical Psychiatry|March 27, 2024
Associations of Valproate Doses With Weight Gain in Adult Psychiatric Patients: A 1-Year Prospective Cohort StudyClaire Grosu, William Hatoum, Marianna Piras, et al.
Therapeutic Drug Monitoring|June 4, 2024
Therapeutic Drug Monitoring of Olanzapine: Effects of Clinical Factors on Plasma Concentrations in Psychiatric PatientsNicolas Ansermot, Harish Vathanarasa, Setareh Ranjbar, et al.
Drug Development Research|October 17, 2019
A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressantsSofia H Kanders, Claudia Pisanu, Marcus Bandstein, et al.
Translational Psychiatry|March 27, 2024
Associations between antipsychotics-induced weight gain and brain networks of impulsivityClaire Grosu, Paul Klauser, Daniella Dwir, et al.
Translational Psychiatry|August 13, 2024
Long-term changes in adiposity markers during and after antidepressant therapy in a community cohortJessica Mwinyi, Marie-Pierre F Strippoli, Sofia H Kanders, et al.
Therapeutic Drug Monitoring|July 22, 2008
Determination of unbound antiretroviral drug concentrations by a modified ultrafiltration method reveals high variability in the free fractionAurélie Fayet, Alexandre Béguin, Begona Martinez de Tejada, et al.
Pharmacopsychiatry|May 20, 2026
High Clozapine Serum Levels Do Not Improve Response: An Observational Study in Patients with Schizophrenia Treated with Clozapine in a Naturalistic SettingXenia M Hart, Dusan Hirjak, Chin B Eap, et al.
Schizophrenia Research|July 10, 2024
Aripiprazole dose associations with metabolic adverse effect: Results from a longitudinal studyMarianna Piras, Iris Popovic, Setareh Ranjbar, et al.
European Journal of Clinical Pharmacology|July 30, 2009
Cannabis and benzodiazepines as determinants of methadone trough plasma concentration variability in maintenance treatment: a transnational studyRichard Hallinan, Séverine Crettol, Kingsley Agho, et al.
Frontiers in Psychiatry|November 27, 2018
Association Between Plasma Caffeine and Other Methylxanthines and Metabolic Parameters in a Psychiatric Population Treated With Psychotropic Drugs Inducing Metabolic DisturbancesAurélie Delacrétaz, Frederik Vandenberghe, Anaïs Glatard, et al.
Pageof 18

Showing results (121-130 of 179) with videos related to

Sort By:
Pageof 18
The Journal of Clinical Psychiatry|March 27, 2024
Associations of Valproate Doses With Weight Gain in Adult Psychiatric Patients: A 1-Year Prospective Cohort StudyClaire Grosu, William Hatoum, Marianna Piras, et al.
Therapeutic Drug Monitoring|June 4, 2024
Therapeutic Drug Monitoring of Olanzapine: Effects of Clinical Factors on Plasma Concentrations in Psychiatric PatientsNicolas Ansermot, Harish Vathanarasa, Setareh Ranjbar, et al.
Drug Development Research|October 17, 2019
A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressantsSofia H Kanders, Claudia Pisanu, Marcus Bandstein, et al.
Translational Psychiatry|March 27, 2024
Associations between antipsychotics-induced weight gain and brain networks of impulsivityClaire Grosu, Paul Klauser, Daniella Dwir, et al.
Translational Psychiatry|August 13, 2024
Long-term changes in adiposity markers during and after antidepressant therapy in a community cohortJessica Mwinyi, Marie-Pierre F Strippoli, Sofia H Kanders, et al.
Therapeutic Drug Monitoring|July 22, 2008
Determination of unbound antiretroviral drug concentrations by a modified ultrafiltration method reveals high variability in the free fractionAurélie Fayet, Alexandre Béguin, Begona Martinez de Tejada, et al.
Pharmacopsychiatry|May 20, 2026
High Clozapine Serum Levels Do Not Improve Response: An Observational Study in Patients with Schizophrenia Treated with Clozapine in a Naturalistic SettingXenia M Hart, Dusan Hirjak, Chin B Eap, et al.
Schizophrenia Research|July 10, 2024
Aripiprazole dose associations with metabolic adverse effect: Results from a longitudinal studyMarianna Piras, Iris Popovic, Setareh Ranjbar, et al.
European Journal of Clinical Pharmacology|July 30, 2009
Cannabis and benzodiazepines as determinants of methadone trough plasma concentration variability in maintenance treatment: a transnational studyRichard Hallinan, Séverine Crettol, Kingsley Agho, et al.
Frontiers in Psychiatry|November 27, 2018
Association Between Plasma Caffeine and Other Methylxanthines and Metabolic Parameters in a Psychiatric Population Treated With Psychotropic Drugs Inducing Metabolic DisturbancesAurélie Delacrétaz, Frederik Vandenberghe, Anaïs Glatard, et al.
Pageof 18